Posts filtered by tags: Amyloid Beta[x]


 

Scientists Find Unusual Form of Iron and Copper in Brains of Alzheimer's Patients

A group of scientists say they’ve made a surprising and potentially very important discovery in the brains of two people with Alzheimer’s disease: traces of a particular form of iron and copper deep inside deposits of amyloid plaque, a key marker of the fatal disease. The find raises more questions about how…Read more...
Tags: Science, Chemistry, Copper, Physical Sciences, Alzheimers Disease, Chemical Elements, Amyloid Beta, Amyloidosis, Branches Of Biology, Native Element Minerals, Health Medical Pharma, Transition Metals, Histopathology, Neil Telling, Amyloid Plaques


Why Scientists Are Worried About a New Alzheimer's Drug Up for FDA Approval

The fate of an experimental dementia drug will be decided within days. On Monday, the Food and Drug Administration is set to announce whether it will approve Biogen’s antibody-based therapy aducanumab as a treatment for Alzheimer’s disease—the first intended to slow down the progression of the incurable ailment. But…Read more...
Tags: Science, Food And Drug Administration, Life Sciences, Biogen, Mild Cognitive Impairment, Aducanumab, Alzheimers Disease, Health Sciences, Monoclonal Antibodies, Amyloid Beta, Cognitive Disorders, Amyloidosis, Branches Of Biology, Health Medical Pharma, Psychiatric Diagnosis, Neurimmune


Pinteon Gets $17M to Tackle Tau in Alzheimer’s, Other Brain Diseases

Beta amyloid grabs most of the headlines and research dollars for Alzheimer’s disease, but efforts to develop drugs targeting that brain protein have largely come up short. Pinteon Therapeutics is trying for a better outcome with drugs that block tau, a different protein that, despite also being associated with Alzheimer’s, has garnered much less attention.Pinteon has spent the past two years quietly developing a tau-targeting drug. On Thursday, the Cambridge, MA-based company announced a $17 m...
Tags: Startups, Boston, Trends, Investing, Alzheimer's Disease, Venture Capital, Pfizer, Biotech, Traumatic Brain Injury, Morningside Ventures, Life Sciences, Clinical Trials, Biogen, Eli Lilly, Beth Israel Deaconess Medical Center, Cambridge MA


Win $2 Million to Solve Alzheimer’s: New Prize Will Reward Fresh Ideas

San Antonio — A Texas billionaire is funding a new competition that will give $4 million to seven individuals who present promising ideas about the cause of Alzheimer’s disease and say they’ll work to prove it.Called the Oskar Fischer Project, the program will give the grand prize winner $2 million of the total, while two others receive $500,000 each, and four more get $250,000 apiece. To top it off, the money comes without requirements to complete the project or to make specific determinations...
Tags: Startups, Texas, Funding, Gift, Trends, Startup, Neuroscience, Research, Bacteria, Alzheimer's Disease, Aluminum, Alzheimer's, Neurology, Viruses, Toxins, Award